Oliver Lamb

Oliver Lamb is a Partner at Óskare Capital, a Paris-based venture capital firm, where he specializes in early-stage life sciences and pharmaceutical investments. He previously served as the firm's UK Director, managing European dealflow and navigating regional tax-advantaged investment frameworks for emerging healthcare startups. In November 2021, Lamb collaborated with Sapphire Capital Partners LLP to co-launch the MEDCAN fund, establishing the first United Kingdom SEIS and EIS investment vehicle dedicated specifically to the medical cannabis sector. This strategic initiative was directly motivated by the firm's proprietary pipeline, which demonstrated that approximately 40 percent of its prospective deals originated from British enterprises seeking early-stage capital with global expansion potential. His current professional focus remains centered on the medical and pharmaceutical industries, specifically targeting life sciences companies that are developing novel therapeutics related to the endocannabinoid system.